GRX vs HYI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Gabelli Healthcare & Wellness Trust (GRX) exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health. The stock is drastically overvalued, trading at $9.16 despite an estimated intrinsic value of $1.05 and a prohibitively high P/E ratio of 61.07. Most concerning is the dividend payout ratio of 440%, which suggests the current 7.42% yield is entirely unsustainable and likely funded by capital rather than earnings. With 0% profit margins and a bearish technical trend, the asset presents a high-risk profile.
The deterministic health profile is critical, highlighted by a Piotroski F-Score of 1/9, indicating severe financial weakness. The fund is trading at a significant premium to its growth-based intrinsic value of $5.25, with a current price of $10.86. A payout ratio of 152% suggests that the 10.50% dividend yield is unsustainable and likely funded by return of capital or leverage. Combined with a 0/100 technical trend, the asset presents as a high-risk value trap.
Compare Another Pair
Related Comparisons
GRX vs HYI: Head-to-Head Comparison
This page compares The Gabelli Healthcare & Wellness Trust (GRX) and Western Asset High Yield Opportunity Fund Inc. (HYI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.